Standout Papers

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesi... 1995 2026 2005 2015 2.2k
  1. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (2000)
    Gabriele Bergers, Rolf A. Brekken et al. Nature Cell Biology
  2. Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with Inhibitors (1997)
    Moosa Mohammadi, Gerald McMahon et al. Science
  3. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. (1999)
    T. Annie T. Fong, Laura K. Shawver et al. PubMed
  4. Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids (1995)
    Ker Yu, William Bayona et al. Journal of Biological Chemistry

Immediate Impact

10 by Nobel laureates 31 from Science/Nature 84 standout
Sub-graph 1 of 20

Citing Papers

The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
2021 Standout
Synthetic Methods for Compounds Having CF3–S Units on Carbon by Trifluoromethylation, Trifluoromethylthiolation, Triflylation, and Related Reactions
2014 Standout
5 intermediate papers

Works of Gerald McMahon being referenced

Structure-Based design and discovery of novel inhibitors of protein tyrosine phosphatases
2003
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival
2001
and 3 more

Author Peers

Author Last Decade Papers Cites
Gerald McMahon 6892 2844 3012 77 11.6k
Evelyn Flynn 6773 3082 2459 66 11.2k
Alfonso Bellacosa 10701 2255 3998 118 14.3k
Dieter Marmé 7932 2123 2043 135 11.2k
David Stokoe 11444 2475 3469 96 15.5k
Helen Turley 9880 7281 3852 147 15.7k
Gary E. Gallick 7626 2860 5944 199 13.6k
Aviv Gazit 5250 912 3232 99 9.6k
Adriana Haimovitz‐Friedman 7785 1748 2332 103 12.2k
Binhua P. Zhou 9896 3625 5978 123 14.5k
Daniel E. Johnson 8289 2198 4222 131 13.2k

All Works

Loading papers...

Rankless by CCL
2026